MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12903-025-06462-9

Медицинская библиотека · BMC oral health · 2025

Levels of peripheral CD4 + and CD8 + T cells and glycaemic control level in patients with both type 2 mellitus diabetes and stage III-IV periodontitis: a randomized controlled trial in Chinese population.

Fan Yadan, Lin Zhikai, Cheng Lan, Ge Linhua

СтатьяРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVE

The aim of this randomized controlled trial was to investigate the short-term glycated haemoglobin (HbA1c) level and proportional variation of peripheral T-lymphocytes status after subgingival scaling and root planing (SRP) therapy in patients with type 2 diabetes mellitus(T2DM) and stage III-IV periodontitis in Chinese population.

METHODS

Fifty-one participants diagnosed T2DM and stage III-IV periodontitis were enrolled. Twenty-seven of them were randomly assigned to receive SRP + OHI treatment immediately and twenty-four only receive OHI and the delayed SRP treatment. Additionally, we divided participants into two stratifications according to initial HbA1c levels. The HbA1c values, proportion of peripheral CD4 + and CD8 + T-lymphocytes, CD4+/CD8 + ratio, and periodontal parameters: plaque index (PI), percentage of bleeding on probing (BOP%), pocket depth (PD) and clinical attachment level (CAL) were measured at baseline, 3 and 6 months.

RESULTS

Forty-eight participants completed the course of our study. At 6-month follow-up, the HbA1c reduction of SRP + OHI group is 0.22 ± 1.12%, greater than 0.07 ± 0.83% of OHI group(P = 0.592). When HbA1c ≥ 7.5%, the HbA1c reduction of SRP + OHI group is 0.74 ± 1.68%, comparing to 0.43 ± 0.91% of OHI group(P = 0.627); when HbA1c < 7.5%, the reductions were - 0.09 ± 0.39 and - 0.17 ± 0.70 respectively(P = 0.716). Both groups showed a slight decrease of peripheral CD4+/CD8 + ratio at 6-month revaluation. An 0.12 ± 0.08 increase of CD4+/CD8 + ratio was observed in SRP + OHI group when HbA1c ≥ 7.5%, which was significantly different to the conrol group(P = 0.040). As to periodontal parameters, PI, BOP% and PD were significantly improved after treatment, while the intergroup analysis in HbA1c ≥ 7.5% group showed no significant reduction of the PI and BOP% s at 6-months.

CONCLUSION

Participants under hyperglycemia (HbA1c ≥ 7.5%) and stage III-IV periodontitis exhibited higher sensitivity of HbA1c level to SRP treatment. When HbA1c ≥ 7.5%, The peripheral CD4+/CD8 + ratio showed a slight increase in the intervention group while only reduction was found in other groups. And the peripheral CD4+/CD8 + ratio of SRP + OHI group in the HbA1c ≥ 7.5% stratification showed a significant increase while other subgroups all present a subtle decrease.

Для цитирования: Fan Yadan, Lin Zhikai, Cheng Lan, Ge Linhua. Levels of peripheral CD4 + and CD8 + T cells and glycaemic control level in patients with both type 2 mellitus diabetes and stage III-IV periodontitis: a randomized controlled trial in Chinese population.. BMC oral health. 2025. DOI: 10.1186/s12903-025-06462-9.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.